Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
British Journal of Clinical Pharmacology
|
August 1, 1990
The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment
E J Begg, R A Robson, R R Bailey, et al.
British Journal of Clinical Pharmacology
|
October 1, 1985
Cortisol does not inhibit prednisolone clearance
P J Meffin, B C Sallustio, Y J Purdie, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
September 1, 1989
The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment
E J Begg, R R Bailey, K L Lynn, et al.
Biochemical Pharmacology
|
May 1, 1988
Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies
R A Robson, J O Miners, A P Matthews, et al.
Clinical Nephrology
|
July 4, 2001
Cost-benefit analysis and prediction of 24-hour proteinuria from the spot urine protein-creatinine ratio
V C Chitalia, J Kothari, E J Wells, et al.
British Journal of Clinical Pharmacology
|
September 1, 1987
Characterisation of theophylline metabolism in human liver microsomes
R A Robson, A P Matthews, J O Miners, et al.
Mutation Research
|
February 1, 1988
Activation of the food-derived mutagen 2-amino-3-methylimidazo[4, 5-f]quinoline by human-liver microsomes
M E McManus, W Burgess, I Stupans, et al.
British Journal of Clinical Pharmacology
|
December 22, 1999
The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing
E J Begg, R A Robson, D A Saunders, et al.
Clinical Nephrology
|
September 1, 1996
Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis
R R Bailey, E J Begg, A H Smith, et al.
Nephron
|
January 1, 1993
Hemorheology and fistula function in home hemodialysis patients following erythropoietin treatment: a prospective placebo-controlled study
B I Shand, A L Buttimore, M A Hurrell, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
British Journal of Clinical Pharmacology
|
August 1, 1990
The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment
E J Begg, R A Robson, R R Bailey, et al.
British Journal of Clinical Pharmacology
|
October 1, 1985
Cortisol does not inhibit prednisolone clearance
P J Meffin, B C Sallustio, Y J Purdie, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
September 1, 1989
The pharmacokinetics of angiotensin converting enzyme inhibitors in patients with renal impairment
E J Begg, R R Bailey, K L Lynn, et al.
Biochemical Pharmacology
|
May 1, 1988
Characterisation of theophylline metabolism by human liver microsomes. Inhibition and immunochemical studies
R A Robson, J O Miners, A P Matthews, et al.
Clinical Nephrology
|
July 4, 2001
Cost-benefit analysis and prediction of 24-hour proteinuria from the spot urine protein-creatinine ratio
V C Chitalia, J Kothari, E J Wells, et al.
British Journal of Clinical Pharmacology
|
September 1, 1987
Characterisation of theophylline metabolism in human liver microsomes
R A Robson, A P Matthews, J O Miners, et al.
Mutation Research
|
February 1, 1988
Activation of the food-derived mutagen 2-amino-3-methylimidazo[4, 5-f]quinoline by human-liver microsomes
M E McManus, W Burgess, I Stupans, et al.
British Journal of Clinical Pharmacology
|
December 22, 1999
The pharmacokinetics of oral fleroxacin and ciprofloxacin in plasma and sputum during acute and chronic dosing
E J Begg, R A Robson, D A Saunders, et al.
Clinical Nephrology
|
September 1, 1996
Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis
R R Bailey, E J Begg, A H Smith, et al.
Nephron
|
January 1, 1993
Hemorheology and fistula function in home hemodialysis patients following erythropoietin treatment: a prospective placebo-controlled study
B I Shand, A L Buttimore, M A Hurrell, et al.
Page
of 9